EP3603669

AQUEOUS FORMULATION, AQUEOUS FORMULATION IN INJECTOR, ANTIBODY PROTEIN DISAGGREGATING AGENT, AND ANTIBODY PROTEIN DISAGGREGATION METHOD

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    30.3.2018
  • EP published:
    19.6.2024
  • EP application number:
    18775644.0
  • Max expiry date:
    29.3.2038
  • Title in English:
    AQUEOUS FORMULATION, AQUEOUS FORMULATION IN INJECTOR, ANTIBODY PROTEIN DISAGGREGATING AGENT, AND ANTIBODY PROTEIN DISAGGREGATION METHOD
  • Language of the patent:
    English

Timeline

Today
30.3.2018EP application
19.6.2024EP Publication

Owner

  • Name:
    Meiji Seika Pharma Co., Ltd.
  • Address:
    4-16, Kyobashi 2-chome Chuo-ku, Tokyo 104-8002, JP
  • Name:
    Dong-A Socio Holdings Co., Ltd.
  • Address:
    64, Cheonho-daero Dongdaemun-gu, Seoul 02587, KR

Inventor

  • Name:
    KAYA, Arpansiree
  • Address:
    Odawara-shi Kanagawa 250-0852, JP
  • Name:
    FUJITA, Michinari
  • Address:
    Odawara-shi Kanagawa 250-0852, JP

Priority

  • Number:
    2017070844
  • Date:
    31.3.2017
  • Country:
    JP

Classification

  • Categories:
    A61K 39/395, A61K 9/08, A61K 47/18, A61K 47/26, A61P 17/06, A61P 37/02

Upload documents